Bulk Manufacturer of Controlled Substances Application: Stepan Company, 54849 [2016-19592]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 159 / Wednesday, August 17, 2016 / Notices
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. ODAG 164]
[Docket No. DEA–392]
Notice of Federal Advisory Committee
Meeting
Department of Justice.
Notice of Federal Advisory
Committee meeting. Request for public
comment.
AGENCY:
Bulk Manufacturer of Controlled
Substances Application: Stepan
Company
ACTION:
ACTION:
Notice of application.
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on April
21, 2016, Stepan Company, Natural
Products Dept., 100 W. Hunter Avenue,
Maywood, New Jersey 07607 applied to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Schedule
mstockstill on DSK3G9T082PROD with NOTICES
Cocaine (9041) .............................
Ecgonine (9180) ...........................
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Dated: August 10, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–19592 Filed 8–16–16; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
16:39 Aug 16, 2016
The National Commission on
Forensic Science will hold meeting
eleven at the time and location listed
below.
DATES:
(1) Public Hearing. The meeting will
be held on September 12, 2016 from
12:30 p.m. to 5:15 p.m. and September
13, 2016 from 8:00 a.m. to 4:00 p.m.
(2) Written Public Comment. Written
public comment regarding National
Commission on Forensic Science
meeting materials can be submitted
through www.regulations.gov starting on
August 29, 2016. Any comments should
be posted to www.regulations.gov no
later than September 28, 2016.
ADDRESSES: Location: National Institute
of Standards and Technology (NIST),
Administrative Building #101, West
Square Conference Room, 100 Bureau
Drive, Gaithersburg, MD 20899. Please
note admittance instructions under the
SUPPLEMENTARY INFORMATION section of
this notice.
FOR FURTHER INFORMATION CONTACT:
Jonathan McGrath, Ph.D., Senior Policy
Analyst at the National Institute of
Justice and Designated Federal Official,
810 7th Street NW., Washington, DC
20531, by email at Jonathan.McGrath@
usdoj.gov by phone at (202) 514–6277.
SUPPLEMENTARY INFORMATION: Agenda:
Open Meeting: The Commission will
meet on September 12, 2016, 12:30 p.m.
to 5:15 p.m. and September 13, 2016,
8:00 a.m. to 4:00 p.m. On September 12,
the Commission will receive a briefing
on technical merit review and
Subcommittee status reports. On
September 13, the Commission will
receive Subcommittee status reports, a
briefing on statistical statements of
relevance, an update on the Forensic
Science Discipline Review from DOJ’s
Office of Legal Policy and a discussion
of ethics issues for NCFS members from
DOJ’s Departmental Ethics Office. Note:
agenda items, including designation of
presentation dates are subject to change.
A final agenda will be posted to the
Commission’s Web site in advance of
the meeting.
Meeting Accessibility: Pursuant to 41
CFR 102–3.140 through 102–3.165 and
the availability of space, the meeting
scheduled for September 12, 2016, 12:30
SUMMARY:
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before October 17, 2016.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
Jkt 238001
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
54849
p.m. to 5:15 p.m. and September 13,
2016, 8:00 a.m. to 4:00 p.m. at NIST is
open to the public and webcast.
New Visitor Access Requirement: For
participants attending in person, please
note that federal agencies, including
NIST, can only accept a state-issued
driver’s license or identification card for
access to federal facilities if such license
or identification card is issued by a state
that is compliant with the REAL ID Act
of 2005 (Pub. L. 109–13), or by a state
that has an extension for REAL ID
compliance. NIST currently accepts
other forms of federal-issued
identification in lieu of a state-issued
driver’s license. Driver’s licenses from
six states and territories are not
compliant and will not be accepted as
identification: Minnesota, Illinois,
Missouri, Washington, and American
Samoa. In addition, NIST will accept
only enhanced driver’s licenses
(identified by the American Flag on the
face of the card) from two states:
Minnesota and Washington State. For a
list of alternative identification, please
visit: https://www.nist.gov/public_
affairs/visitor/.
Non U.S. Citizens Please Note: All
foreign national visitors who do not
have permanent resident status and who
wish to register for the above meeting
must supply additional information.
Failure to provide this information prior
to arrival will result, at a minimum, in
significant delays (up to 24 hours) in
entering the facility. Authority to gather
this information is derived from United
States Department of Commerce
Department Administrative Order
(DAO) number 207–12. When on-line
registration is open, the required NIST–
1260 form will be available. The NIST–
1260 form needs to be submitted at least
5 business days in advance of the
meeting.
Written Comments: Pursuant to
section 10(a)(3) of the FACA and 41 CFR
102–3.105(j) and 102–3.140, the public
or interested organizations may submit
written comments to the Commission in
response to the stated agenda and
meeting material. Meeting material,
including work products will be made
available on the Commission’s Web site:
https://www.justice.gov/ncfs.
Oral Comments: In addition to written
statements, members of the public may
present oral comments at 5:00 p.m. on
September 12, 2016 and at 3:45 p.m. on
September 13, 2016. Those individuals
interested in making oral comments
should indicate their intent through the
on-line registration form and time will
be allocated on a first-come, first-served
basis. Time allotted for an individual’s
comment period will be limited to no
more than 3 minutes. If the number of
E:\FR\FM\17AUN1.SGM
17AUN1
]]>Agencies
[Federal Register Volume 81, Number 159 (Wednesday, August 17, 2016)]
[Notices]
[Page 54849]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-19592]
[[Page 54849]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Stepan
Company
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before October 17, 2016.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated her
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on April
21, 2016, Stepan Company, Natural Products Dept., 100 W. Hunter Avenue,
Maywood, New Jersey 07607 applied to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Cocaine (9041)............................. II
Ecgonine (9180)............................ II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
Dated: August 10, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-19592 Filed 8-16-16; 8:45 am]
BILLING CODE 4410-09-P
